Home > Name List By 2 > 2-[4, 6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2- hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-d... Canada

CAS No 1403-66-3 , 2-[4,
6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-
hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Search by region : Canada

  • Name: 2-[4,
    6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-
    hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol
  • Synonyms: Uromycine; Cidomycin;Garamycin; Gentamicins;2-[4,
    6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-
    hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol; GENTAMYCIN; gentamicin; Refobacin; Gentamycinum; Gentacycol; Gentavet;
  • CAS Registry Number:
  • Density: 1.3 g/cm3
  • Safety Statements: Poison by intravenous, intraperitoneal, intramuscular, and subcutaneous routes. Mildly toxic by ingestion. Experimental teratogenic and reproductive effects. Mutation data reported. Human systemic effects: change in motor activity, changes in vestibular functions, distorted perceptions, eye hemorrhage, hallucinations, kidney changes, motor activity changes, trigeminal nerve sensory changes, vestibular function changes, visual field changes. Affects the peripheral nervous system by intravenous route. An antibiotic. When heated to decomposition it emits acrid smoke and irritating fumes. See also GENTAMYCIN SULFATE.
  • EINECS: 215-765-8
  • Molecular Weight: 477.59542
  • InchiKey: CEAZRRDELHUEMR-UHFFFAOYSA-N
  • InChI: InChI=1S/C21H43N5O7/c1-9(25-3)13-6-5-10(22)19(31-13)32-16-11(23)7-12(24)
    17(14(16)27)33-20-15(28)18(26-4)21(2,29)8-30-20/h9-20,25-29H,5-8,
    22-24H2,1-4H3
  • Molecular Formula: C21H43N5O7
  • Molecular Structure:CAS No:1403-66-3 2-[4,<br />6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-<br />hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol

Related products

Select to

1403-66-3 GENTAMICIN SULFATE

  • Canada Synth?se AptoChem Inc. [Manufacturer]
  • Tel: 514-496-4252
  • Fax: 514-496-4253
  • Address: Synth?se AptoChem Inc.
    6100 Royalmount Ave
    Montreal, QC
    Canada
    H4P 2R2 null,nullCanada
Contact Supplier

Select to

References of 2-[4,
6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-
hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol
Title: Gentamicin
CAS Registry Number: 1403-66-3
CAS Name: Gentamycin
Literature References: Antibiotic complex produced by fermentation of Micromonospora purpurea or M. echinospora and variants thereof: M. J. Weinstein et al., Antimicrob. Agents Chemother. 1963, 1. Isoln, purification and characterization: J. P. Rosselet et al., ibid. 14. Industrial pats.: G. M. Luedemann, M. J. Weinstein; Charney, US 3091572; US 3136704 (1963, 1964, both to Schering). Consists of three closely related components, gentamicins C1, C2, C1a, and also gentamicin A which differs from the other members of the complex but is similar to kanamycin C, q.v. Separation of gentamicin C components: H. Maehr, C. P. Schaffner, J. Chromatogr. 30, 572 (1967); Wagman et al., ibid. 34, 210 (1968). Structures contain 2-deoxystreptamine, q.v., linked to two saccharide units, these being garosamine and a purpurosamine in the C series gentamicins. Structure studies: D. J. Cooper et al., J. Chem. Soc. C 1971, 960, 2876, 3126. Structure of gentamicin A: H. Maehr, C. P. Schaffner, J. Am. Chem. Soc. 89, 6787 (1967); 92 1697 (1969). Sepn and structures of gentamicins A1 to A4: Nagabhushan et al., J. Org. Chem. 40, 2830, 2835 (1975). Synthetic studies: W. Meyer zu Reckendorf, Bischof, Ber. 105, 2546 (1972); M. Chmielewski et al., Carbohydr. Res. 70, 275 (1979). Review of activity, toxicity and clinical pharmacology: J. Black et al., Antimicrob. Agents Chemother. 1963, 138-147. Comprehensive description: B. E. Rosenkrantz et al., Anal. Profiles Drug Subs. 9, 295-340 (1980). Determn in serum by immunoassay: H. A. Holt et al., J. Antimicrob. Chemother. 34, 747 (1994). Review of clinical use: S. B. Shrimpton et al., ibid. 31, 599-606 (1993). Clinical effect on chloride transport in cystic fibrosis: M. Wilschanski et al., Am. J. Respir. Crit. Care Med. 161, 860 (2000).
Properties: White amorphous powder, mp 102-108°. [a]D25 +146°. Freely sol in water; sol in pyridine, DMF, in acidic media with salt formation; moderately sol in methanol, ethanol, acetone. Practically insol in benzene, halogenated hydrocarbons.
Melting point: mp 102-108°
Optical Rotation: [a]D25 +146°
 
Derivative Type: Gentamicin C1
CAS Registry Number: 25876-10-2
Molecular Formula: C21H43N5O7
Molecular Weight: 477.60
Percent Composition: C 52.81%, H 9.07%, N 14.66%, O 23.45%
Properties: mp 94-100°. [a]D25 +158°.
Melting point: mp 94-100°
Optical Rotation: [a]D25 +158°
 
Derivative Type: Gentamicin C2
CAS Registry Number: 25876-11-3
Molecular Formula: C20H41N5O7
Molecular Weight: 463.57
Percent Composition: C 51.82%, H 8.91%, N 15.11%, O 24.16%
Properties: mp 107-124°. [a]D25 +160°.
Melting point: mp 107-124°
Optical Rotation: [a]D25 +160°
 
Derivative Type: Gentamicin C1a
CAS Registry Number: 26098-04-4
CAS Name: O-3-Deoxy-4-C-methyl-3-(methylamino)-b-L-arabinopyranosyl-(1?6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-a-D-erythro-hexopyranosyl-(1?4)]-2-deoxy-D-streptamine
Synonyms: gentamicin D
Molecular Formula: C19H39N5O7
Molecular Weight: 449.54
Percent Composition: C 50.76%, H 8.74%, N 15.58%, O 24.91%
 
Derivative Type: Gentamicin A
CAS Registry Number: 13291-74-2
CAS Name: O-2-Amino-2-deoxy-a-D-glucopyranosyl-(1?4)-O-[3-deoxy-3-(methylamino)-a-D-xylopyranosyl-(1?6)]-2-deoxy-D-streptamine
Molecular Formula: C18H36N4O10
Molecular Weight: 468.50
Percent Composition: C 46.15%, H 7.75%, N 11.96%, O 34.15%
 
Derivative Type: Hydrochloride
Properties: mp 194-209°. [a]D25 +113°. Freely sol in water, methanol; slightly in ether. Practically insol in other organic solvents.
Melting point: mp 194-209°
Optical Rotation: [a]D25 +113°
 
Derivative Type: C complex sulfate
CAS Registry Number: 1405-41-0
Trademarks: Alcomicin (Alcon); Cidomycin (Aventis); Duragentam (Merck KGaA); Garamycin (Schering-Plough); Garasol (Schering-Plough); Genoptic (Allergan); Gentacin (Schering-Plough); Gent-Ak (Akorn); Gentalline (Schering-Plough); Gentalyn (Essex); Gentibioptal (Farmila); Genticin (Roche); Gentocin (Schering-Plough); Gentogram (Merck-Sante); Gent-Ophtal (Winzer); Lugacin (Sandoz); Ophtagram (Chauvin); Pangram (Virbac); Refobacin (Merck KGaA); Septopal (Merck KGaA); Sulmycin (Essex)
Properties: White, hygroscopic powder, mp 218-237°. [a]D25 +102°. Sol in ethylene glycol, formamide. LD50 in mice (mg base/kg): 430 i.p.; 485 s.c.; 75 i.v.; >9050 orally (Black).
Melting point: mp 218-237°
Optical Rotation: [a]D25 +102°
Toxicity data: LD50 in mice (mg base/kg): 430 i.p.; 485 s.c.; 75 i.v.; >9050 orally (Black)
 
Therap-Cat: Antibacterial.
Therap-Cat-Vet: Antibacterial.
Keywords: Antibacterial (Antibiotics); Aminoglycosides.